Landmarks Berhad:企業の戦略・SWOT・財務情報

◆英語タイトル:Landmarks Berhad - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C11942
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Landmarks Berhad – Strategy, SWOT and Corporate Finance Report
Summary

Landmarks Berhad – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Landmarks Berhad (Landmarks) is an investment holding company. The company, through its subsidiaries, is involved in the hospitality and property investment businesses. Landmarks operates hotels and resorts, and is also focused on property development, wellness and spa, and township development business. It operates hotels under the brands of The Andaman and V Integrated Wellness (VIW) and Treasure Bay. Landmarks’ hotels are equipped with the lobby lounge, business centers, golf course, fitness centers, fun park, holistic and live entertainment facilities. It also offers construction, project financing, and consultancy services. The company operates through its subsidiaries across Malaysia, Australia, Indonesia, Singapore and Republic of Seychelles. Landmarks is headquartered in Kuala Lumpur, Malaysia.

Scope

- Detailed information on Landmarks Berhad required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Landmarks Berhad in the form of a SWOT analysis
- An in-depth view of the business model of Landmarks Berhad including a breakdown and examination of key business segments
- Intelligence on Landmarks Berhad’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Landmarks Berhad, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Landmarks Berhad and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Landmarks Berhad as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Landmarks Berhad’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Landmarks Berhad: Company Overview 9
Landmarks Berhad: Overview and Key Facts 9
Landmarks Berhad: Overview 9
Landmarks Berhad: Key Facts 9
Landmarks Berhad: Key Employees 11
Landmarks Berhad: Key Employee Biographies 12
Landmarks Berhad: Major Products and Services 13
Landmarks Berhad: Company History 14
Landmarks Berhad: Management Statement 15
Landmarks Berhad: Locations and Subsidiaries 17
Landmarks Berhad: Key Competitors 18
Landmarks Berhad: Company Analysis 19
Landmarks Berhad: Business Description 19
Landmarks Berhad: SWOT Analysis 20
Landmarks Berhad: SWOT Overview 20
Landmarks Berhad: Strengths 20
Landmarks Berhad: Weaknesses 21
Landmarks Berhad: Opportunities 21
Landmarks Berhad: Threats 21
Landmarks Berhad: Corporate Financial Deals Activity 23
Landmarks Berhad: Financial Deals Overview 23
Landmarks Berhad: Top Deals 2014 – 2018YTD* 24
Landmarks Berhad: Capital Raising 25
Landmarks Berhad: Recent Developments 26
Landmarks Berhad: News and Events Summary 26
Landmarks Berhad: Corporate Governance 26
Landmarks Berhad: Financial Performance 27
Appendix 28
Contact Us 28
Methodology 28
About MarketLine 29

List of Tables
Table 1: Landmarks Berhad: Key Facts
Table 2: Landmarks Berhad: Key Employees
Table 3: Landmarks Berhad: Company History
Table 4: Landmarks Berhad: Locations and Subsidiaries
Table 5: Landmarks Berhad: Key Competitors
Table 6: Landmarks Berhad: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Landmarks Berhad: Top Deals 2014 - 2018YTD*
Table 8: Landmarks Berhad: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 9: Landmarks Berhad: Capital Raising by Deal Type (2014 - YTD*2018)
Table 10: Landmarks Berhad: News and Events Summary
Table 11: Landmarks Berhad: Corporate Governance
Table 12: Landmarks Berhad: Financial Performance

List of Figures
Figure 1: Landmarks Berhad: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Landmarks Berhad: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 3: Landmarks Berhad: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Landmarks Berhad:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HUGO BOSS AG:企業の戦略・SWOT・財務情報
    HUGO BOSS AG - Strategy, SWOT and Corporate Finance Report Summary HUGO BOSS AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Taylor Corporation:企業の戦略・SWOT・財務情報
    Taylor Corporation - Strategy, SWOT and Corporate Finance Report Summary Taylor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Viriom Inc-製薬・医療分野:企業M&A・提携分析
    Summary Viriom Inc (Viriom) focuses on the development of antivirals for HIV treatment and prevention. The company’s lead pipeline product candidate Elpida, is a bioavailable prodrug, and VM-1500A, a non-nucleoside HIV reverse transcriptase inhibitor. Its partner portfolio includes Roche, ChemDiv, I …
  • Oriental Bank of Commerce:企業の戦略・SWOT・財務分析
    Oriental Bank of Commerce - Strategy, SWOT and Corporate Finance Report Summary Oriental Bank of Commerce - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Simons Group Ltd:企業の戦略・SWOT・財務分析
    Simons Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Simons Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • The Bangchak Petroleum PCL (BCP):石油・ガス:M&Aディール及び事業提携情報
    Summary The Bangchak Petroleum PCL (Bangchak) is an oil and gas company. It carries out import of crude oil from both indigenous and overseas sources, and refines it into finished petroleum products. Its refinery produces gasoline, gasohol and diesel products. The company markets its petroleum produ …
  • Escorts Ltd:企業の戦略・SWOT・財務情報
    Escorts Ltd - Strategy, SWOT and Corporate Finance Report Summary Escorts Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • WellSpring Pharmaceutical Corp-製薬・医療分野:企業M&A・提携分析
    Summary WellSpring Pharmaceutical Corp (WellSpring Pharma) is a healthcare products provider that offers medicinal products. The company develops over the counter consumer pharmaceuticals and new prescription drugs. Its products include bonine, gelusil, emetrol, bactine, micatin, glaxal base, FDS, b …
  • The New York Times Company (NYT):企業の財務・戦略的SWOT分析
    The New York Times Company (NYT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Etam Developpement SCA:戦略・SWOT・企業財務分析
    Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report Summary Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Werner Enterprises, Inc.:企業の戦略・SWOT・財務分析
    Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Southern Co (SO):石油・ガス:M&Aディール及び事業提携情報
    Summary Southern Co is a gas and electric utility holding company. It generates, distributes, markets and trades electricity and distributes gas. It uses a variety of sources for electricity generation including coal, oil and gas, nuclear and hydro. The company also distributes natural gas through t …
  • Birks Group Inc (BGI):企業の財務・戦略的SWOT分析
    Birks Group Inc (BGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sumitomo Electric Industries Ltd (5802):電力:M&Aディール及び事業提携情報
    Summary Sumitomo Electric Industries Ltd (Sumitomo) is a manufacturing company that develops, manufactures, and sells various products related to electronics, info communications, automotive, industrial materials, and environment and energy. The company’s product portfolio includes wiring harnesses, …
  • KAZ Minerals PLC:企業の戦略・SWOT・財務分析
    KAZ Minerals PLC - Strategy, SWOT and Corporate Finance Report Summary KAZ Minerals PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ferrovial SA (FER):企業の財務・戦略的SWOT分析
    Ferrovial SA (FER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Deloitte Touche Tohmatsu Limited:企業の戦略・SWOT・財務分析
    Deloitte Touche Tohmatsu Limited - Strategy, SWOT and Corporate Finance Report Summary Deloitte Touche Tohmatsu Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • EnPro Industries Inc (NPO):企業の財務・戦略的SWOT分析
    Summary EnPro Industries Inc (EnPro) is a diversified company that offers engineering solutions. The company designs, develops, manufactures and markets proprietary engineered industrial products. It provides commercial vehicle wheel-end components. EnPro offers sealing solutions for a wide range of …
  • General Motors Co (GM):企業の財務・戦略的SWOT分析
    General Motors Co (GM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Tetraphase Pharmaceuticals Inc (TTPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Tetraphase Pharmaceuticals Inc (Tetraphase) is a pharmaceutical company that discovers and develops antibiotic resistance medicines. The company’s products under clinical development include eravacycline, TP-271, and TP-6076. It develops products for the treatment of respiratory diseases cau …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆